EQL Pharma AB (publ) (STO: EQL)
Sweden
· Delayed Price · Currency is SEK 79.80
0.00 (0.00%)
At close: Dec 20, 2024
EQL Pharma AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is April - March.
Millions SEK. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,319 | 1,229 | 1,087 | 974 | 994 | 392 | Upgrade
|
| Market Cap Growth | 102.25% | 13.10% | 11.64% | -2.05% | 153.33% | 12.03% | Upgrade
|
| Enterprise Value | 2,456 | 1,317 | 1,075 | 1,010 | 980 | 377 | Upgrade
|
| Last Close Price | 79.80 | 42.30 | 37.40 | 33.50 | 34.20 | 13.50 | Upgrade
|
| PE Ratio | 74.57 | 54.15 | 35.15 | 30.86 | 95.88 | 144.94 | Upgrade
|
| PS Ratio | 7.33 | 4.65 | 4.18 | 2.38 | 5.55 | 5.45 | Upgrade
|
| PB Ratio | 11.72 | 6.92 | 7.02 | 7.88 | 10.90 | 4.85 | Upgrade
|
| P/TBV Ratio | 169.50 | 42.91 | 20.82 | 38.62 | - | 15.77 | Upgrade
|
| P/FCF Ratio | - | - | 40.02 | 23.63 | 16.67 | 63.44 | Upgrade
|
| P/OCF Ratio | - | - | 39.36 | 23.28 | 16.55 | 58.67 | Upgrade
|
| EV/Sales Ratio | 7.76 | 4.99 | 4.14 | 2.47 | 5.47 | 5.24 | Upgrade
|
| EV/EBITDA Ratio | 44.31 | 33.94 | 22.70 | 24.92 | 59.15 | 54.29 | Upgrade
|
| EV/EBIT Ratio | 51.50 | 40.38 | 26.01 | 26.01 | 85.05 | 83.26 | Upgrade
|
| EV/FCF Ratio | -125.90 | - | 39.58 | 24.52 | 16.43 | 61.02 | Upgrade
|
| Debt / Equity Ratio | 0.75 | 0.68 | 0.43 | 0.62 | 0.96 | 0.33 | Upgrade
|
| Debt / EBITDA Ratio | 2.67 | 2.98 | 1.37 | 1.83 | 5.26 | 3.87 | Upgrade
|
| Debt / FCF Ratio | - | - | 2.45 | 1.85 | 1.46 | 4.35 | Upgrade
|
| Asset Turnover | 0.90 | 0.80 | 0.99 | 1.86 | 1.09 | 0.64 | Upgrade
|
| Inventory Turnover | 1.59 | 1.74 | 2.69 | 7.47 | 3.62 | 1.64 | Upgrade
|
| Quick Ratio | 0.47 | 0.53 | 0.83 | 0.77 | 0.56 | 0.75 | Upgrade
|
| Current Ratio | 1.24 | 1.22 | 1.43 | 1.25 | 1.03 | 1.41 | Upgrade
|
| Return on Equity (ROE) | 17.11% | 13.66% | 22.21% | 29.37% | 12.04% | 3.40% | Upgrade
|
| Return on Assets (ROA) | 8.51% | 6.18% | 9.87% | 11.00% | 4.39% | 2.50% | Upgrade
|
| Return on Capital (ROIC) | 10.30% | 7.85% | 12.27% | 12.84% | 5.03% | 2.88% | Upgrade
|
| Earnings Yield | 1.34% | 1.85% | 2.84% | 3.24% | 1.04% | 0.69% | Upgrade
|
| FCF Yield | -0.84% | -1.01% | 2.50% | 4.23% | 6.00% | 1.58% | Upgrade
|
| Buyback Yield / Dilution | 1.96% | 1.56% | -1.59% | - | 3.37% | 0.60% | Upgrade
|
| Total Shareholder Return | 1.96% | 1.56% | -1.59% | - | 3.37% | 0.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.